Overview This page contains the latest trade data of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale. In 2023, Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale were the world's 4131st most traded product, with a total trade of $179M. Between 2022 and 2023 the exports of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale decreased by -39.9%, from $297M to $179M. Trade in Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale represent 0.00079% of total world trade.
Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale are a part of Medicaments; (not goods of heading no. 3002, 3005 or 3006) of two....
Exports In 2023 the top exporters of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale were Ireland ($42.8M), Romania ($33.1M), Germany ($24.6M), United States ($22.8M), and China ($13.7M).
Imports In 2023 the top importers of Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale were Hungary ($23.7M), France ($19.1M), Vietnam ($14.7M), China ($13.5M), and Sweden ($13.3M).
Ranking Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine or norephedrine or their salts; not packaged for retail sale ranks 608th in the Product Complexity Index (PCI).